Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists Read more
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses Read more
Iterion Therapeutics Secures $17 Million to Advance Development of Tegavivint in Multiple Tumor Settings Read more
Johnson & Johnson Announces Submission of European Conditional Marketing Authorisation Application to the EMA for its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate Read more
Gene Therapy for Muscular Disorders: Sarepta, Novartis, Solid Bio, Genethon, 4DMT & More Join the Line-Up Read more